Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Neural tube defects

Joel G. Ray
CMAJ January 18, 2005 172 (2) 160; DOI: https://doi.org/10.1503/cmaj.1041541
Joel G. Ray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 Canadian Medical Association or its licensors

We appreciate Chris Delaney's points about our study of ethnicity and neural tube defects.1 First, we did not discuss the lower risk of neural tube defects in the group of 10 009 women categorized as “other” because of the nondescript nature of this category. Second, nondifferential misclassification of exposure (in our case, ethnicity) might be expected to bias the results toward the null. Thus, the observed effect size of the associated risk of neural tube defects among women of First Nations descent was probably an underestimation, not the false-positive result that Delaney contends. Third, we have yet to see someone perform an adjustment for multiple comparisons in a single logistic regression analysis conducted on five levels (in our case, ethnicity). By analogy, if we had examined weight as the exposure, divided into quintiles, with the risk of neural tube defects as the outcome, we would not have adjusted for multiple comparisons as Delaney suggests. The reference that Delaney cites does not support this idea either.2 Given that neural tube defects are becoming so rare in Canada3 and that data on maternal ethnicity is not typically recorded in large databases, we are unsure if there will be another opportunity in the near future to address the question of ethnicity and risk of neural tube defects with greater statistical power or accuracy.

Fu-Lin Wang and colleagues correctly suggest that some Ontario First Nations women may not undergo maternal serum screening and are thus underrepresented in our study. They are incorrect, however, in stating that “[f]ailure to include all pregnant First Nations women ... in the denominator for a risk calculation ... could lead to overestimation of the risk for neural tube defects.” Rather, our risk estimate was calculated as all women within a given ethnic group whose children had neural tube defects and who underwent maternal serum screening (the numerator) divided by all women within the same ethnic group who underwent maternal serum screening (the denominator), which provides a valid prevalence rate ratio for those women. Because Wang and colleagues' Alberta live-birth data on neural tube defects do not capture the 50% or more of affected pregnancies that end in termination, as they admit, they are much more likely to miss a large number of First Nations women who may undergo termination in the presence of a fetal neural tube defect. For now, our “premature” conclusions are based on the some of the best available data in Canada.

We agree with Vinita Dubey that ethnicity may simply be a confounder of neural tube defects, related to poor folic acid intake. Not only might estimating periconceptional use of folic acid tablets within a maternal serum screening program improve future research, but it could also help to focus on which women are not receiving supplements.4

Heather Dean and coauthors are right: all women of reproductive age with type 1 or type 2 diabetes mellitus should be taking a daily folic acid supplement if a future pregnancy — planned or unplanned — is possible. Observational data strongly support both this notion and the value of multidisciplinary preconception care among women with diabetes mellitus,5 no matter where they live in Canada.

References

  1. 1.↵
    Ray JG, Vermeulen MJ, Meier C, Cole DEC, Wyatt PR. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 2004; 171(4):343-5.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996; 86:726-8.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Ray JG. Folic acid food fortification in Canada. Nutr Rev 2004;62(6 Pt 2):S35-9.
  4. 4.↵
    Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. Br J Obstet Gynaecol 2004; 111: 399-408.
    OpenUrl
  5. 5.↵
    Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001;94:435-44.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (2)
CMAJ
Vol. 172, Issue 2
18 Jan 2005
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neural tube defects
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neural tube defects
Joel G. Ray
CMAJ Jan 2005, 172 (2) 160; DOI: 10.1503/cmaj.1041541

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Neural tube defects
Joel G. Ray
CMAJ Jan 2005, 172 (2) 160; DOI: 10.1503/cmaj.1041541
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Pitfalls of analyzing perinatal outcomes by health care provider
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire